Sickle Cell Disease
Showing NaN - NaN of 46
Sickle Cell Disease Trial in Washington, Bethesda (Niacin-ER, Placebo, L-NMMA)
Completed
- Sickle Cell Disease
- Niacin-ER
- +3 more
-
Washington, District of Columbia
- +1 more
Sep 3, 2020
A 3-year, Prospective, Non-interventional, Multicenter Registry
Completed
- Sickle Cell Disease
-
Little Rock, Arkansas
- +41 more
Dec 5, 2019
Sickle Cell Disease Trial in Worldwide (Prasugrel, Placebo)
Sickle Cell Disease, Thalassemia Trial in Oakland, Washington, Paris (CordIn)
Terminated
- Sickle Cell Disease
- Thalassemia
- CordIn
-
Oakland, California
- +2 more
Jun 3, 2019
Sickle Cell Disease, Pulmonary Hypertension Trial in United Kingdom, United States (Sildenafil, Placebo)
Terminated
- Sickle Cell Disease
- Pulmonary Hypertension
- Sildenafil
- Placebo
-
Oakland, California
- +8 more
Dec 7, 2015
Sickle Cell Disease Trial in Washington (Dextromethorphan, Codeine, Morphine)
Withdrawn
- Sickle Cell Disease
- Dextromethorphan
- +2 more
-
Washington, District of ColumbiaChildren's National Medical Center
Dec 19, 2014
Sickle Cell Disease Trial in United States (Lexiscan)
Completed
- Sickle Cell Disease
-
Washington, District of Columbia
- +6 more
Feb 5, 2014
Sickle Cell Disease, Vaso-occlusive Crisis, Acute Chest Syndrome Trial in United States (A-001, Placebo)
Completed
- Sickle Cell Disease
- +2 more
- A-001
- Placebo
-
Washington, District of Columbia
- +5 more
Jan 30, 2014
Sickle Cell Disease Trial in United States (Single blood transfusion, Standard care)
Completed
- Sickle Cell Disease
- Single blood transfusion
- Standard care
-
Oakland, California
- +23 more
Apr 16, 2013
Sickle Cell Disease Trial in United States (High Demand / Low Infusion, PCA Dosing Plan)
Terminated
- Sickle Cell Disease
- High Demand / Low Infusion
- PCA Dosing Plan
-
Oakland, California
- +27 more
Apr 16, 2013
Sickle Cell Disease, Sickle Cell Anemia Trial in United States (Low Dose ICA-17043, High dose ICA-17043, Placebo)
Completed
- Sickle Cell Disease
- Sickle Cell Anemia
- Low Dose ICA-17043
- +2 more
-
Birmingham, Alabama
- +18 more
Jul 13, 2011
Sickle Cell Disease, Iron Overload, Hemolytic Anemia Trial in Canada, United States (Deferasirox (ICL670), Deferoxamine (DFO))
Completed
- Sickle Cell Disease
- +2 more
- Deferasirox (ICL670)
- Deferoxamine (DFO)
-
Birmingham, Alabama
- +58 more
May 23, 2011
Sickle Cell Disease Trial in United States (TRF-1101, Placebo)
Terminated
- Sickle Cell Disease
- TRF-1101
- Placebo
-
Washington, District of Columbia
- +5 more
May 7, 2009